Luke Thompson

Luke Thompson is a Scientist at 272BIO Limited since January 2021, following a role as Business Development Executive at Aptamer Group from June 2019 to December 2020. Prior experience includes serving as a Postdoctoral Research Fellow at Indiana University School of Medicine from March 2018 to March 2019, focusing on novel interactors of the COPI Coatomer complex and the Survival of Motor Neuron protein in Professor Elliot Androphy's laboratory. Luke completed a PhD in Cell/Cellular and Molecular Biology at the University of St Andrews, where research under Dr. Judith Sleeman involved investigating Sm proteins, resulting in a first-author publication in the Journal of Cell Science. Educational background includes a Bachelor of Science (Hons) in Biological Sciences (Biochemistry) from the University of Leicester, obtained in 2013.